Importantly, some tumor cell death was always observed at the dose of the chemotherapeutic drug required to induce immunogenic cell injury in the surviving cells, indicating that a certain threshold of tumor cell damage had to be exceeded in order to induce CD8+ T-cell responses. This evidence concerns the gene CD8A and neoplasm.